740 related articles for article (PubMed ID: 22089420)
21. Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
Cheng M; Rizwan A; Jiang L; Bhujwalla ZM; Glunde K
Neoplasia; 2017 Aug; 19(8):617-627. PubMed ID: 28654865
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors.
Kumar M; Arlauckas SP; Saksena S; Verma G; Ittyerah R; Pickup S; Popov AV; Delikatny EJ; Poptani H
Mol Cancer Ther; 2015 Apr; 14(4):899-908. PubMed ID: 25657334
[TBL] [Abstract][Full Text] [Related]
23. The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.
Trousil S; Kaliszczak M; Schug Z; Nguyen QD; Tomasi G; Favicchio R; Brickute D; Fortt R; Twyman FJ; Carroll L; Kalusa A; Navaratnam N; Adejumo T; Carling D; Gottlieb E; Aboagye EO
Oncotarget; 2016 Jun; 7(24):37103-37120. PubMed ID: 27206796
[TBL] [Abstract][Full Text] [Related]
24. Choline phospholipid metabolism: a target in cancer cells?
Ackerstaff E; Glunde K; Bhujwalla ZM
J Cell Biochem; 2003 Oct; 90(3):525-33. PubMed ID: 14523987
[TBL] [Abstract][Full Text] [Related]
25. Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.
Agarwal K; Hariprasad G; Rani K; Sharma U; Mathur SR; Seenu V; Parshad R; Jagannathan NR
Sci Rep; 2017 May; 7(1):2221. PubMed ID: 28533512
[TBL] [Abstract][Full Text] [Related]
26. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.
Inazu M
Biopharm Drug Dispos; 2014 Nov; 35(8):431-49. PubMed ID: 24532461
[TBL] [Abstract][Full Text] [Related]
27. Malignant transformation: the role of MRS.
Jiang L; Wijnen JP; Glunde K
Eur J Radiol; 2012 Sep; 81 Suppl 1():S66-8. PubMed ID: 23083608
[No Abstract] [Full Text] [Related]
28. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
[TBL] [Abstract][Full Text] [Related]
29. HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells.
Ward CS; Eriksson P; Izquierdo-Garcia JL; Brandes AH; Ronen SM
PLoS One; 2013; 8(4):e62610. PubMed ID: 23626839
[TBL] [Abstract][Full Text] [Related]
30. ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies.
Gokhale S; Xie P
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34202989
[TBL] [Abstract][Full Text] [Related]
31. In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.
Lu J; Li Y; Li YA; Wang L; Zeng AR; Ma XL; Qiang JW
J Transl Med; 2022 Feb; 20(1):92. PubMed ID: 35168606
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
[TBL] [Abstract][Full Text] [Related]
33. In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature.
Begley JK; Redpath TW; Bolan PJ; Gilbert FJ
Breast Cancer Res; 2012 Apr; 14(2):207. PubMed ID: 22515594
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
Glunde K; Jie C; Bhujwalla ZM
Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
[TBL] [Abstract][Full Text] [Related]
35. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.
Shah T; Stasinopoulos I; Wildes F; Kakkad S; Artemov D; Bhujwalla ZM
NMR Biomed; 2012 May; 25(5):746-54. PubMed ID: 21953546
[TBL] [Abstract][Full Text] [Related]
37. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study.
Senaratne R; Milne AM; MacQueen GM; Hall GB
Psychiatry Res; 2009 Jun; 172(3):205-9. PubMed ID: 19386476
[TBL] [Abstract][Full Text] [Related]
38. A Preliminary Study on the Diagnostic Efficacy of Proton Magnetic Resonance Spectroscopy at 3.0T in Rabbit With VX2 Liver Tumor.
Liao R; Zhang D; Li X; Ma J; Yu J; Yang C; Xiong H; Zhou B; Huang X; Tang Z
Technol Cancer Res Treat; 2021; 20():15330338211036852. PubMed ID: 34372732
[TBL] [Abstract][Full Text] [Related]
39. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
[TBL] [Abstract][Full Text] [Related]
40. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
